Cambridge Vasculitis and Lupus Training Centre logo

Mobile menu open

Clinical trials and studies

Introduction to appear here....

Vasculitis

ObiVas

the information cvccvcvcvcvcvcvcv
View this trial

  • Good Ides 2
  • MICROBIOME
  • COVID-19 Antibody Responses
  • AVACOSTAR
  • Alentis
  • VARIED (sample ethics for ACQ and PRO V)
  • COMBIVAS Biomarker study (Sample ethics)
  • EME NIHR134720 (G111920)
  • Novartis CLNP023R12201 Iptacopan
  • ABAGART
  • AvOID Avacopan in CKD
  • ALXN1820-ANCA-320
  • Vaccine responses study
  • COMBIVAS
  • HAVEN
  • PROTECT V
EGPA
  • OCEAN
  • NS229
  • MANDARA
  • RACEMATE
  • VCRC registry
Lupus Nephritis
  • REGENCY
  • Novartis  CLNP023K12201 Lupus
  • Amgen 2024003
  • Alexion ALXN2050-NEPH-201
SLE
  • ALLEGORY (Gazyva in Extrarenal Lupus)
  • 3TR
  • Iptacopan
  • Otsuka Voclosporin PASS
  • IM026-024 Lupus (BMS)
  • Lavender - AZ_275711 skin  lupus
  • GSK4527363 SLE Part B
  • FIRST - rituximab
GN studies

IgA

Membranous